4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-040660
CFO sold 20,000 shares at an average $38.92 ($778,399)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Horn Howard CFO | 2020-07-01 | Sale | −9,100 | $37.72 | $343,275 | 218,677 | D: show line 1 in the form |
| Horn Howard CFO | 2020-07-01 | Sale | −500 | $38.78 | $19,392 | 218,177 | D: show line 2 in the form |
| Horn Howard CFO | 2020-07-01 | Sale | −400 | $39.33 | $15,732 | 217,777 | D: show line 3 in the form |
| Horn Howard CFO | 2020-07-02 | Sale | −10,000 | $40.00 | $400,000 | 207,777 | D: show line 4 in the form |
| Open-market sales · 20,000 sh · avg $38.92 · $778,399 | |||||||
Loading xslF345X03/doc4.xml…